Casi Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary

CASI Pharmaceuticals

12/05/2022 14:32

* CASI Pharmaceuticals Inc  CASI.OQ  reported a quarterly
adjusted
loss of 6 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 9 cents per share.
    * Revenue rose 58% to $9.06 million from a year ago; 
analysts
expected $9.23 million. 
    * CASI Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 6 cents​.
    * The mean earnings estimate of analysts had fallen by
about 36.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * CASI Pharmaceuticals Inc shares had fallen by 59.0% this
quarter and lost 58.5% so far this year.
    * The company reported a quarterly loss of $8.6 million.
    * Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 01:32 p.m.  ​All
figures in US dollars unless otherwise stated